NCT05112315 - Clinical Impact of the IBox As an Early Intervention TooL | Biotech Hunter

Enrollment

507

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions

Kidney DiseasesKidney Disease, ChronicKidney Transplant RejectionKidney Transplant; ComplicationsKidney FailureKidney Failure, ChronicKidney Dysfunction

Interventions

DEVICE

Predigraft

The Subject randomized to the Predigraft will benefit from Predigraft, a remote monitoring software that issues an alert to the investigator when the allograft survival prediction calculated by the iBox algorithm is decreasing. This follow-up is on top of the site's standard of care.

Trial Locations (16)

6020

Medizinische Universität Innsbruck, Innsbruck

20251

Universitätsklinikum Hamburg-Eppendorf, Hamburg

31400

CHU Rangueil, Toulouse

40225

Universitätsklinikum Düsseldorf AÖR, Düsseldorf

46026

Hospital Universitari i Politècnic La Fe, Valencia

75010

Hôpital Saint-Louis, Paris

75015

Hôpital Necker, Paris

75020

Hôpital Tenon, Paris

6423906

Sourasky Medical Center - Ichilov Hospital, Tel Aviv

08003

Hospital Del Mar - Parc de Salut Mar, Barcelona

08025

Fundació Puigvert, Barcelona

B15 2GW

Queen Elizabeth Hospital, Birmingham

LS9 7TF

Leeds Teaching Hospital NHS Trust, Leeds

SE1 9RT

Guy's & Saint Thomas' NHS Foundation Trust, London

SE5 9RS

King's College Hospital, London

OX3 7LE

Oxford Transplant Centre, Oxford